ENTERO vs JARO: Stock Comparison
ENTERO HEALTHCARE SOLU L is the larger company by market capitalisation. ENTERO HEALTHCARE SOLU L shows faster revenue growth, while JARO INS OF TEC MG N RE L shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
ENTERO leads 3; JARO leads 8 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | ENTERO | JARO |
|---|---|---|
| Sector | Consumer Services | Consumer Services |
| Industry | Pharmacy Retail | E-Learning |
Price
| Metric | ENTERO | JARO |
|---|---|---|
| Live Price | ₹1,503.9 | ₹405.15 |
| Day Change | -5.12% | -0.82% |
| Volume | 1.65 L | 56,494 |
| 52-Week High | ₹1,920 | ₹736 |
| 52-Week Low | ₹944 | ₹383.5 |
| Distance from 52W High | -21.67% | -44.95% |
Valuation
| Metric | ENTERO | JARO |
|---|---|---|
| Market Cap | ₹6,558 Cr | ₹913 Cr |
| P/E Ratio | 52.28x | 16.08x |
| P/B Ratio | 3.88x | 2.52x |
| EPS | ₹8.77 | ₹5.02 |
| Book Value | ₹402.67 | ₹161.84 |
| Dividend Yield | 0% | 1.22% |
Growth
| Metric | ENTERO | JARO |
|---|---|---|
| Revenue Growth (TTM YoY) | 42.6% | -1.8% |
| EPS Growth (TTM YoY) | 9.1% | 3.9% |
| Qtr Sales Growth | 0% | 0% |
| Qtr Profit Growth | 0% | 0% |
Profitability & Leverage
| Metric | ENTERO | JARO |
|---|---|---|
| ROE | 1.6% | 14.68% |
| ROCE | 2.01% | 16.92% |
| Net Margin | 1.75% | 17.05% |
| Operating Margin | 9.99% | 26.81% |
| Debt to Equity | 0.06x | 0x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | ENTERO | JARO |
|---|---|---|
| Promoter Holding | 14.4%▼ 0.01 pp | 61.43%▲ 4.15 pp |
| FII Holding | 4.37%▲ 0.34 pp | 0.75%▼ 0.04 pp |
| DII Holding | 15.48%▼ 1.14 pp | 2.7%▼ 2.17 pp |
| Public Holding | 27.75%▲ 0.82 pp | 33.32%▼ 3.75 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ENTERO HEALTHCARE SOLU L and JARO INS OF TEC MG N RE L.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.